Skip to main content
ZIM Laboratories Limited logo

ZIM Laboratories Limited — Investor Relations & Filings

Ticker · ZIMLAB ISIN · INE518E01015 LEI · 335800YPYG1O3ML66R52 BSE.NS Manufacturing
Open in API
Filings indexed 423 across all filing types
Latest filing 2025-06-05 Annual Report
Country IN India
Listing BSE.NS ZIMLAB

About ZIM Laboratories Limited

https://www.zimlab.in/

ZIM Laboratories Limited is a research-driven organization specializing in the development and manufacturing of innovative drug delivery solutions. The company focuses on enhancing the efficacy and patient compliance of generic medicines through advanced formulation technologies. Its core product portfolio includes Oral Disintegrating Films (ODF), Oral Disintegrating Tablets (ODT), pellets, and taste-masked granules. Utilizing proprietary technology platforms like Thinoral, the company provides differentiated products across various therapeutic segments, including central nervous system, cardiovascular, and gastrointestinal health. ZIM Laboratories offers end-to-end services from product development and clinical trials to commercial manufacturing. The organization serves a global clientele, providing value-added generic formulations that address specific patient needs such as ease of administration and rapid onset of action.

Recent filings

Filing Released Lang Actions
General Updates
Annual Report Classification · 100% confidence The document is titled as a corrigendum to the Annual Report for the Financial Year 2024-25 and mentions that it is a revised Annual Report correcting typographical errors in the Corporate Governance Report and Independent Auditors Report sections of the Annual Report. The document includes detailed sections typical of an Annual Report such as Corporate Overview, Statutory Reports, Financial Statements, Management Discussion and Analysis, Board's Report, Corporate Governance Report, and detailed financial and business information. The length of the document (15,000 characters) and the presence of comprehensive financial and business data confirm it is the full Annual Report rather than a brief announcement or a certification. Therefore, the document should be classified as an Annual Report (10-K). FY 2025
2025-06-05 English
Copy of Newspaper Publication
AGM Information Classification · 100% confidence The document is a submission to stock exchanges regarding the publication of newspaper advertisements for the 41st Annual General Meeting (AGM) of the company scheduled on June 27, 2025. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30 and 47, which pertain to disclosures and advertisements related to corporate events such as AGMs. The document includes copies of the newspaper advertisements and a formal letter from the company secretary. There is no detailed financial data, management discussion, or report content; rather, it is an announcement of the publication of AGM-related materials. Therefore, this fits the category of AGM Information (AGM-R).
2025-06-04 English
General Updates
Report Publication Announcement Classification · 95% confidence The document is a letter dated June 3, 2025, from ZIM Laboratories Limited addressed to stock exchanges and shareholders. It informs about the availability of the Annual Report for the financial year 2024-25 via a web-link for members who have not registered their email addresses. It also mentions the upcoming 41st Annual General Meeting (AGM) scheduled for June 27, 2025, to be held via video conferencing. The letter primarily serves as an intimation or notification about the Annual Report's availability and the AGM details, rather than containing the full Annual Report itself. The document is relatively short (5699 characters) and does not include financial statements or detailed report content. Therefore, according to the "Menu vs Meal" rule, this is an announcement about the report, not the report itself. Hence, the appropriate classification is Report Publication Announcement (RPA).
2025-06-03 English
General Updates
Annual Report Classification · 100% confidence The document is a letter addressed to stock exchanges dated 03.06.2025, explicitly stating it encloses the Annual Report for the Financial Year 2024-25. It references SEBI Listing Obligations and Disclosure Requirements Regulation, 2015, which mandates submission of annual reports. The text includes detailed content typical of an annual report: corporate overview, statutory reports, financial statements, management discussion and analysis, board reports, corporate governance, and sustainability assessment. The document length is substantial (15,000 characters), indicating it is the report itself, not merely an announcement or a link to the report. Therefore, this document is the full Annual Report for FY 2024-25. FY 2025
2025-06-03 English
Shareholders meeting
AGM Information Classification · 95% confidence The document is a notice dated 03.06.2025 from ZIM Laboratories Limited addressed to stock exchanges regarding the 41st Annual General Meeting (AGM) scheduled for 27th June 2025. It includes the Notice of the 41st AGM and a copy of the Annual Report for the financial year 2024-25. The document contains detailed agenda items typical of an AGM notice, such as adoption of audited financial statements, appointment/reappointment of directors, appointment of auditors, and other resolutions. The presence of the full AGM notice and the Annual Report indicates this is a filing related to AGM Information, not just an announcement or a proxy solicitation. The document length (15,000 characters) and content confirm it is the actual AGM notice and related materials, not merely a brief announcement or a proxy statement. Therefore, the appropriate classification is AGM Information (AGM-R).
2025-06-03 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated 29.05.2025 from ZIM LABORATORIES LIMITED addressed to stock exchanges, disclosing the schedule of an Investors / Analysts Meet on 03rd June 2025. It references compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events or information. The document does not contain any financial data, detailed report, or analysis. It is an announcement about a scheduled meeting rather than a report or transcript. The length is only 2942 characters, which is short and typical for a regulatory announcement. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-05-29 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.